Medicine and Dentistry
N(g),n(g) Dimethylarginine
100%
Methylglyoxal
50%
Protein
41%
Serum
33%
Advanced Glycation End-Product
25%
Glyceraldehyde
25%
Patient
16%
Therapeutic Procedure
16%
Vasculitis
16%
Endothelial Dysfunction
16%
Oral Antidiabetic Agent
16%
Cardiovascular System
8%
Hypertension
8%
Combination Therapy
8%
Inpatient
8%
Nitric Oxide Synthase
8%
In Vitro
8%
Glucose
8%
Ankle
8%
Arterial Stiffness
8%
Diabetes Mellitus
8%
Coronary Risk
8%
Regression Analysis
8%
Cardiovascular Disease
8%
High Density Lipoprotein Cholesterol
8%
Maturity Onset Diabetes of the Young
8%
C Reactive Protein
8%
Liquid Chromatography-Mass Spectrometry
8%
Outpatient
8%
Impaired Glucose Tolerance
8%
Pharmacology, Toxicology and Pharmaceutical Science
N(g),n(g) Dimethylarginine
100%
Methylglyoxal
50%
Protein
41%
Advanced Glycation End Product
25%
Glyceraldehyde
25%
Diabetes Mellitus
16%
Endothelial Dysfunction
16%
Oral Antidiabetic Agent
16%
Hypertension
8%
Nitric Oxide Synthase
8%
Human
8%
Glucose
8%
C Reactive Protein
8%
Cardiovascular Disease
8%
Vasculitis
8%
High Density Lipoprotein Cholesterol
8%
Impaired Glucose Tolerance
8%
Non Insulin Dependent Diabetes Mellitus
8%
Coronary Risk
8%
Biochemistry, Genetics and Molecular Biology
Methylglyoxal
50%
Protein
41%
Blood Level
25%
Advanced Glycation End-Product
25%
Glyceraldehyde
25%
Cholesterol
8%
Human
8%
Glucose
8%
Nitric Oxide Synthase
8%
C-Reactive Protein
8%
Impaired Glucose Tolerance
8%
Liquid Chromatography Tandem Mass Spectrometry
8%
High-Density Lipoprotein
8%
Arterial Stiffness
8%